Geboes, K <br/><br/>
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Nov 2001 
 - 1819-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2001.01105.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Aged<br/>Drug Administration Schedule<br/>Endoscopy<br/>Enzyme Inhibitors--administration & dosage<br/>Esophagitis--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Gastric Mucosa--drug effects<br/>Gastritis--drug therapy<br/>Gastroesophageal Reflux--drug therapy<br/>Helicobacter Infections--complications<br/>Helicobacter pylori--pathogenicity<br/>Humans<br/>Lansoprazole<br/>Male<br/>Middle Aged<br/>Omeprazole--administration & dosage<br/>Risk Factors<br/>Stomach Neoplasms--etiology